Rising Rheumatoid Arthritis Cases Boosting Hydroxychloroquine Market Is Supporting Development Across The Hydroxychloroquine Market

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Market Size Is Forecasted For The Hydroxychloroquine Market By 2030 Based On Its 2026 Value?

The hydroxychloroquine market has demonstrated robust growth in recent years. Its valuation is anticipated to increase from $2.38 billion in 2025 to $2.52 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.2%. This historical expansion can be attributed to several factors, including the high prevalence of malaria in endemic regions, its established application in various autoimmune disorders, increasing awareness regarding the benefits of hydroxychloroquine, its widespread availability through hospital and retail pharmacies, and the growing clinical adoption for conditions such as rheumatoid arthritis and lupus.

The hydroxychloroquine market is expected to experience robust expansion in the coming years, with its valuation projected to reach $3.26 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.6%. This anticipated growth is fueled by several factors, including ongoing research into its potential applications for COVID-19, the development of innovative formulations and delivery methods, the expansion of online pharmacy channels, increased governmental health initiatives aimed at malaria prevention, and a surge in investments for clinical trials and off-label studies. Significant trends during the forecast period include the increasing utilization of hydroxychloroquine for both malaria prevention and treatment, its growing adoption in the management of rheumatoid arthritis and lupus, an uptick in off-label uses and clinical research related to COVID-19, the proliferation of tablet formulations and injectable variants, and broadened distribution through hospital, online, and retail pharmacies.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3235&type=smp

What Important Drivers Are Powering The Hydroxychloroquine Market Growth?

The expanding incidence of rheumatoid arthritis is anticipated to accelerate the hydroxychloroquine market’s growth. Rheumatoid arthritis is an autoimmune and inflammatory disorder where the immune system mistakenly attacks healthy cells, causing inflammation in affected body regions. Hydroxychloroquine provides effective treatment for rheumatoid arthritis by reducing inflammation and easing symptoms, thereby enhancing patients’ quality of life. For example, data from June 2023 by the Centers for Disease Control and Prevention, a US-based health protection agency, indicated that in the United States, 54.4 million adults had been diagnosed with arthritis, a figure projected to increase to 78 million by the year 2040. Consequently, the increasing prevalence of rheumatoid arthritis is set to boost the hydroxychloroquine market.

Hydroxychloroquine Market Driver: Impact Of Rising Healthcare Expenditure On The Growth Of The Hydroxychloroquine Market

Which Segment-Based Categories Are Covered In The Hydroxychloroquine Market?

The hydroxychloroquine market covered in this report is segmented –

1) By Drug Activity: Anti-Malarial Drug, Anti-Rheumatic Drug, Lupus Suppressant Drug, Anti COVID-19 Drug, Other Drug Activity

2) By Formulation: Tablets, Injection

3) By Application: Malaria, Rheumatoid Arthritis, Lupus Erythematosus, COVID-19, Other Applications

4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Specialty Drug Stores, Retail Pharmacy

Subsegments:

1) By Anti-Malarial Drug: Treatment Of Malaria, Prophylaxis For Malaria

2) By Anti-Rheumatic Drug: Treatment Of Rheumatoid Arthritis, Treatment Of Juvenile Idiopathic Arthritis

3) By Lupus Suppressant Drug: Treatment Of Systemic Lupus Erythematosus

4) By Anti COVID-19 Drug: Treatment Of COVID-19 Symptoms

5) By Other Drug Activity: Treatment Of Other Autoimmune Disorders, Additional Off-label uses

Which Firms Are Competing In The Hydroxychloroquine Market?

Major companies operating in the hydroxychloroquine market are Bayer AG, Dr. Reddy’s Laboratories Ltd., Zydus Group, Ipca Laboratories Ltd., Wallace Pharma, Teva Pharmaceuticals Inc., Mylan Pharmaceuticals Inc., Novartis AG, Intas Pharmaceuticals Ltd., Lupin Limited, Shanghai Zhongxi Sanwei Pharmaceutical Co. Ltd., Torrent Pharmaceuticals Ltd., Hikma Pharmaceuticals plc, Sandoz International GmbH, Cipla Limited, Shenhua Pharmaceutical Co. Ltd., Sanofi S.A., Macleod Pharmaceuticals Ltd., Laurus Labs, TAJ Pharmaceuticals, Wuhan Wuyao Pharmaceutical Co. Ltd., Concordia Healthcare, Pfizer Inc., Cadila Pharmaceuticals, Hetero Drugs Ltd., Jubilant Generics Limited, Alembic Pharmaceuticals Limited, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma USA Inc., Alkem Laboratories Ltd., Glenmark Pharmaceuticals Ltd., Unichem Laboratories Ltd., Wockhardt Limited, Emcure Pharmaceuticals Ltd., Strides Pharma Science Ltd., Indoco Remedies Ltd.

Access The Complete Hydroxychloroquine Market Report:

https://www.thebusinessresearchcompany.com/report/hydroxychloroquines-global-market-report

Which Region Is The Dominant Market In The Hydroxychloroquine Market?

North America was the largest region in the hydroxychloroquine market in 2025. Middle East is expected to be the fastest-growing region in the hydroxychloroquine market report. The regions covered in the hydroxychloroquine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Hydroxychloroquine Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=3235&type=smp

Browse Through More Reports Similar to the Global Hydroxychloroquine Market 2026, By The Business Research Company

Cardiovascular Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiovascular-drugs-global-market-report

Dermatology Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/dermatology-drugs-global-market-report

Gastrointestinal Drug Market Report 2026

https://www.thebusinessresearchcompany.com/report/gastrointestinal-drug-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795